Augmentin '125' and Camptosar drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Augmentin '125' (amoxicillin; clavulanate potassium) and Camptosar (irinotecan hydrochloride). Common drug interactions include angina pectoris among females and abdominal hernia among males.

The phase IV clinical study analyzes what interactions people have when they take Augmentin '125' and Camptosar. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.

What is Augmentin '125'?

Augmentin '125' has active ingredients of amoxicillin; clavulanate potassium. It is often used in sinusitis. eHealthMe is studying from 10,452 Augmentin '125' users. Check the latest studies of Augmentin '125'.

What is Camptosar?

Camptosar has active ingredients of irinotecan hydrochloride. eHealthMe is studying from 7,145 Camptosar users. Check the latest studies of Camptosar.

On Jul, 19, 2026

12 people who take Augmentin '125' and Camptosar together, and have interactions are studied.

Augmentin '125' and Camptosar drug interactions.

What are the common drug interactions of Augmentin '125' and Camptosar, by gender? *:

female:

Angina pectoris (chest pain due to ischemia of the heart muscle)
Chest pain
Inflammation
Peritoneal haemorrhage (peritoneal bleeding)
Pruritus (severe itching of the skin)
Rash
Toxic skin eruption (skin breakdown due to toxic substance)
Erythema (redness of the skin)
Rash macular (small, flat red spots)

male:

Abdominal hernia
Abdominal pain
Bone neoplasm malignant (cancer of bone)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiomegaly (increased size of heart than normal)
Carotid bruit (sound heard over the carotid artery area during auscultation)
Cerumen impaction
Chest pain
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Colon cancer

What are the common drug interactions of Augmentin '125' and Camptosar, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Chest pain
Abdominal hernia
Bone disorder
Bone neoplasm malignant (cancer of bone)
Bundle branch block right (absence of transmission of electric impulses from the atrioventricular (av) bundle of his to the right ventricle)
Cardiomegaly (increased size of heart than normal)
Carotid bruit (sound heard over the carotid artery area during auscultation)
Cerumen impaction
Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
Colon cancer

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 58.33%
Peritoneal Carcinoma (peritoneal cancer): 2 people, 16.67%
Colon Cancer: 2 people, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Augmentin '125' and Camptosar?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously